£15.6M
Oppenheimer led the Series C financing, which will support US expansion and the development of new diagnostic tools.
Perspectum
Developing advanced medical imaging and artificial intelligence tools to improve the diagnosis of metabolic diseases and cancer.
£51.6MTotal raised
A medical technology company developing advanced digital tools and artificial intelligence software to improve the diagnosis of metabolic diseases, cancer, and inflammatory conditions. Its technology enhances standard magnetic resonance imaging machines to provide quantitative assessments of organ health as non-invasive alternatives to biopsies.
Categories
Founders
RB
Rajarshi Banerjee
CEO
Rajarshi is a doctor and the founder and chief executive officer of Perspectum, having previously held clinical and research roles within the NHS and the University of Oxford.
LinkedIn
Matthew Robson
Matthew serves as Chief Technology Officer and co-founder of Perspectum Diagnostics, following academic and research roles in biomedical imaging and medical systems.
LinkedInMB
Michael Brady
Michael is a founder and image analysis scientist who previously chaired Perspectum Ltd and held a professorship in oncological imaging at Oxford University.
LinkedInInvestors
- £15.6M
- $36.0M
Funding history
$36.0M
The medtech firm has raised $36m in a round led by Oppenheimer Holdings to accelerate its product pipeline and scale American operations.